153 related articles for article (PubMed ID: 36786086)
21. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
[TBL] [Abstract][Full Text] [Related]
22. Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.
Layton TJ; Barnett ML; Hicks TR; Jena AB
N Engl J Med; 2018 Nov; 379(22):2122-2130. PubMed ID: 30485780
[TBL] [Abstract][Full Text] [Related]
23. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
[TBL] [Abstract][Full Text] [Related]
24. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
25. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
[TBL] [Abstract][Full Text] [Related]
26. Traumatic Brain Injury in Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Nationwide Longitudinal Study.
Chang HK; Hsu JW; Wu JC; Huang KL; Chang HC; Bai YM; Chen TJ; Chen MH
J Clin Psychiatry; 2018 Oct; 79(6):. PubMed ID: 30403445
[TBL] [Abstract][Full Text] [Related]
27. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
[TBL] [Abstract][Full Text] [Related]
28. Consumption of sugar-sweetened beverages before 2 years of age and attention-deficit/hyperactivity disorder.
Kim S; Shin J; Cha HR; Ha EK; Kim JH; Han MY
Ann Nutr Metab; 2024 May; ():. PubMed ID: 38815568
[TBL] [Abstract][Full Text] [Related]
29. Exposure to Manganese in Drinking Water during Childhood and Association with Attention-Deficit Hyperactivity Disorder: A Nationwide Cohort Study.
Schullehner J; Thygesen M; Kristiansen SM; Hansen B; Pedersen CB; Dalsgaard S
Environ Health Perspect; 2020 Sep; 128(9):97004. PubMed ID: 32955354
[TBL] [Abstract][Full Text] [Related]
30. Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life.
Kazda L; McGeechan K; Bell K; Thomas R; Barratt A
JAMA Netw Open; 2022 Oct; 5(10):e2236364. PubMed ID: 36227598
[TBL] [Abstract][Full Text] [Related]
31. Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011.
Hong M; Kwack YS; Joung YS; Lee SI; Kim B; Sohn SH; Chung US; Yang J; Bhang SY; Hwang JW; Choi HY; Oh IH; Lee YJ; Bahn GH
Asia Pac Psychiatry; 2014 Dec; 6(4):379-85. PubMed ID: 25277653
[TBL] [Abstract][Full Text] [Related]
32. Neurodevelopment at 6 years of age in children with atopic dermatitis.
Kim JH; Yi YY; Ha EK; Cha HR; Han MY; Baek HS
Allergol Int; 2023 Jan; 72(1):116-127. PubMed ID: 36058807
[TBL] [Abstract][Full Text] [Related]
33. Change in household income and risk for attention deficit hyperactivity disorder during childhood: A nationwide population-based cohort study.
Choi Y; Shin J; Cho KH; Park EC
J Epidemiol; 2017 Feb; 27(2):56-62. PubMed ID: 28142012
[TBL] [Abstract][Full Text] [Related]
34. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
[TBL] [Abstract][Full Text] [Related]
35. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
[TBL] [Abstract][Full Text] [Related]
36. Behavioural disorders after prenatal exposure to anaesthesia for maternal surgery.
Ing C; Silber JH; Lackraj D; Olfson M; Miles C; Reiter JG; Jain S; Chihuri S; Guo L; Gyamfi-Bannerman C; Wall M; Li G
Br J Anaesth; 2024 May; 132(5):899-910. PubMed ID: 38423824
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
Shin JY; Roughead EE; Park BJ; Pratt NL
BMJ; 2016 May; 353():i2550. PubMed ID: 27245699
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder.
Curtin K; Fleckenstein AE; Keeshin BR; Yurgelun-Todd DA; Renshaw PF; Smith KR; Hanson GR
Neuropsychopharmacology; 2018 Dec; 43(13):2548-2555. PubMed ID: 30209407
[TBL] [Abstract][Full Text] [Related]
40. Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan.
Chen VC; Chan HL; Wu SI; Lee M; Lu ML; Liang HY; Dewey ME; Stewart R; Lee CT
JAMA Netw Open; 2019 Aug; 2(8):e198714. PubMed ID: 31390039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
